Scottsdale 2/1/2014 4:00:00 AM
QualityStocks News - Medizone International (MZEI) Receives Patent Protection for Anthrax Elimination
QualityStocks would like to highlight Medizone International, Inc. (OTCQB: MZEI) a research and development company engaged in developing its AsepticSure® System to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools, and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures.
In the company’s news,
Medizone International announced it has been granted its fourth patent for AsepticSure, its pioneering enclosed space room disinfection system. The U.S. Patent and Trademark Office has issued U.S. Patent number 8,636,951, “Bio-Terrorism Counteraction Using Ozone and Hydrogen Peroxide,” to the company.
This latest patent follows on the heels of patent protection for Medizone’s healthcare-related patent applications. The company has now been awarded a patent for its government variant of AsepticSure, which is intended to be used by defense agencies as a response to biological attacks on critical buildings, infrastructure, and resources.
Medizone International has successfully eliminated bacillus atropheus and bacillus subtilis at its Innovation Park, Queens University laboratories. Both of these bacteria are globally recognized study surrogates for anthrax, which is one of the most difficult weaponized pathogens to kill. The ability to eliminate these anthrax surrogates with the AsepticSure technology approaches assurance that Medizone International now has the ability to restore critical public infrastructure to service after a biological attack without damaging crucial and costly equipment, such as communication systems. This problem has plagued militaries for decades without, until now, a solution.
“To now have patent protection granted for this system,” said Medizone CEO Edwin Marshall, “should allow the company protected access to a potentially lucrative government market due to the unique capability of AsepticSure’s government variant.”
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
